Carperitide (ANP analog) infusion increased plasma adiponectin in acute decompensated heart failure patients with diabetes, revealing a beneficial metabolic effect of natriuretic peptide therapy.
Key findingCarperitide (ANP analog) infusion increased plasma adiponectin in acute decompensated heart failure patients with diabetes, revealing a beneficial met
What the researchers found
Carperitide (ANP analog) infusion increased plasma adiponectin in acute decompensated heart failure patients with diabetes, revealing a beneficial metabolic effect of natriuretic peptide therapy.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2009.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure patients with diabetes mellitus.
Circulation journal : official journal of the Japanese Circulation Society, 73(12), 2264-9
Citation
Yamaji, Masayuki; Tsutamoto, Takayoshi; Tanaka, Toshinari; Kawahara, Chiho; Nishiyama, Keizo; Yamamoto, Takashi; Fujii, Masanori; Horie, Minoru. (2009). Effect of carperitide on plasma adiponectin levels in acute decompensated heart failure patients with diabetes mellitus.. Circulation journal : official journal of the Japanese Circulation Society, 73(12), 2264-9.